Literature DB >> 16361294

Assisted reproductive therapies and imprinting disorders--a preliminary British survey.

A G Sutcliffe1, C J Peters, S Bowdin, K Temple, W Reardon, L Wilson, J Clayton-Smith, L A Brueton, W Bannister, E R Maher.   

Abstract

BACKGROUND: Recent reports have suggested a higher risk of Beckwith-Wiedemann syndrome (BWS) and Angelman syndrome (AS) after assisted reproductive technologies (ARTs), but it is unclear whether this might also apply to other disorders of genomic imprinting.
METHODS: We contacted families of children with BWS, AS, Prader-Willi syndrome (PWS) and transient neonatal diabetes mellitus (TNDM) to determine use of ART.
RESULTS: A statistically significant increased frequency of ART in children with BWS was confirmed [2.9%, 95% confidence interval (CI) 1.4-6.3% vs 0.8% expected] but there was no significant association with PWS or TNDM. Consideration of the molecular subgroup of BWS and AS suggested the feasibility of association with ART.
CONCLUSIONS: These differences may relate to variations in (i) the molecular mechanisms for disordered imprinting in the different disorders and (ii) the susceptibility of specific imprinting control regions to ART-associated methylation alterations (epimutations).

Entities:  

Mesh:

Year:  2005        PMID: 16361294     DOI: 10.1093/humrep/dei405

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  63 in total

1.  Loss of genomic imprinting in mouse embryos with fast rates of preimplantation development in culture.

Authors:  Brenna A Market Velker; Michelle M Denomme; Mellissa R W Mann
Journal:  Biol Reprod       Date:  2012-05-10       Impact factor: 4.285

2.  In vitro culture of mouse embryos reduces differential gene expression between inner cell mass and trophectoderm.

Authors:  G Giritharan; L Delle Piane; A Donjacour; F J Esteban; J A Horcajadas; E Maltepe; P Rinaudo
Journal:  Reprod Sci       Date:  2012-03       Impact factor: 3.060

3.  Outlier DNA methylation levels as an indicator of environmental exposure and risk of undesirable birth outcome.

Authors:  Jayashri Ghosh; Monica Mainigi; Christos Coutifaris; Carmen Sapienza
Journal:  Hum Mol Genet       Date:  2015-11-12       Impact factor: 6.150

Review 4.  Preeclampsia: a view through the danger model.

Authors:  Elizabeth A Bonney
Journal:  J Reprod Immunol       Date:  2007-05-04       Impact factor: 4.054

5.  Abnormal DNA Methylation of Imprinted Loci in Human Preimplantation Embryos.

Authors:  Xiaoyun Shi; Shiling Chen; Haiyan Zheng; Lele Wang; Yaqin Wu
Journal:  Reprod Sci       Date:  2014-01-09       Impact factor: 3.060

6.  Health of IVM children.

Authors:  Emre Basatemur; Alastair Sutcliffe
Journal:  J Assist Reprod Genet       Date:  2011-04-07       Impact factor: 3.412

Review 7.  The impact of assisted reproductive technologies on genomic imprinting and imprinting disorders.

Authors:  Asli Uyar; Emre Seli
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

8.  Clinical outcomes following ICSI cycles using surgically recovered sperm and the impact of maternal age: 2004-2015 SART CORS registry.

Authors:  A M Mahesan; S Sadek; V Moussavi; T Vazifedan; A Majeed; T Cunningham; S Oehninger; S Bocca
Journal:  J Assist Reprod Genet       Date:  2018-06-20       Impact factor: 3.412

9.  45,X/46,XY mosaicism and Oculo-Auriculo-Vertebral Spectrum following an IVF pregnancy: a report and a discussion of their interrelationships.

Authors:  Gareth Baynam; Jack Goldblatt
Journal:  J Maxillofac Oral Surg       Date:  2009-11-21

10.  Impaired imprinted X chromosome inactivation is responsible for the skewed sex ratio following in vitro fertilization.

Authors:  Kun Tan; Lei An; Kai Miao; Likun Ren; Zhuocheng Hou; Li Tao; Zhenni Zhang; Xiaodong Wang; Wei Xia; Jinghao Liu; Zhuqing Wang; Guangyin Xi; Shuai Gao; Linlin Sui; De-Sheng Zhu; Shumin Wang; Zhonghong Wu; Ingolf Bach; Dong-Bao Chen; Jianhui Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.